The number of people with susceptibility test result for rifampicin in Uganda
Uganda: The number of people with susceptibility test result for rifampicin was 74.76 in 2021. ▬ Flat
Latest (2021)
74.76
Change on year
up 19.4%
World rank
101st
of 146 countries
All-time high
99.33
in 2019
All-time low
61.36
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Uganda, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Uganda stood at 74.76.
The figure is up 19.4% on the previous year and up 21.8% over five years.
That places Uganda 101st out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Uganda, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 61.36 | — |
| 2018 | 87.4 | +42.4% |
| 2019 | 99.33 | +13.6% |
| 2020 | 62.61 | -37.0% |
| 2021 | 74.76 | +19.4% |
Uganda compared with similar countries
- Uganda's 74.76 is above the median for low income countries, which is 37.16, 2.0× the median. (13 countries reporting)
- Uganda's 74.76 is above the median for Sub-Saharan Africa, which is 61.16, 1.2× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 82.7 | 61.36 | 99.33 | 3 |
| 2020s | 68.69 | 62.61 | 74.76 | 2 |
Countries ranked near Uganda
More health data for Uganda
- Un projection of annual infant deaths, annual growth rate -2.2 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.34 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 853.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 6,666 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 111 (2025)
- Population ages 00-04, female, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0787 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.34 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Uganda?
- The number of people with susceptibility test result for rifampicin in Uganda was 74.76 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Uganda?
- The highest recorded value was 99.33 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Uganda?
- The lowest recorded value was 61.36 in 2017.
- How does Uganda rank for the number of people with susceptibility test result for rifampicin?
- Uganda ranks 101st out of 146 countries with data for 2021.
- Where does this Uganda data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).